Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size by Product
2.3.2 Market Size by Assay Type
2.3.3 Market Size by End-User
2.3.4 Market Size by Application
2.4 Market Share & Bps Analysis by Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material, Reagent & Biotechnology Suppliers
3.4.2 GPCR Research, Drug Discovery & Technology Developers
3.4.3 Clinical Development, Manufacturing & Distribution Providers
3.4.4 End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 GPCR Drug Discovery & Therapeutics Metrics
4.1.1 Share (%) of approved pharmaceutical drugs targeting GPCR pathways globally.
4.1.2 Growth (%) in GPCR-focused drug discovery programmes and clinical trials during 2025 and 2026.
4.1.3 Increase (%) in development of GPCR-targeted therapies for oncology, cardiovascular, neurological, and metabolic disorders.
4.2 Research, Assay & Screening Technology Metrics
4.2.1 Share (%) of GPCR research demand generated by cell-based assays, biosensors, and high-throughput screening technologies.
4.2.2 Growth (%) in adoption of AI-enabled molecular modeling and computational drug discovery platforms.
4.2.3 Increase (%) in utilization of fluorescence, luminescence, and label-free detection technologies in GPCR analysis.
4.3 Pharmaceutical, Biotechnology & Academic Research Metrics
4.3.1 Share (%) of GPCR market demand generated by pharmaceutical companies, biotechnology firms, and academic research institutions.
4.3.2 Growth (%) in investments toward receptor biology, precision medicine, and biomarker discovery research globally.
4.3.3 Increase (%) in partnerships between CROs, biopharmaceutical companies, and AI drug discovery firms.
4.4 Clinical Development & Manufacturing Metrics
4.4.1 Share (%) of GPCR therapeutic development outsourced to CROs and contract manufacturing organizations (CMOs).
4.4.2 Growth (%) in biologics and small-molecule manufacturing capacity supporting GPCR-targeted drug development.
4.4.3 Increase (%) in regulatory approvals and commercialization of novel GPCR-targeted therapeutics globally.
4.5 Innovation & Precision Medicine Metrics
4.5.1 Share (%) of GPCR R&D investments allocated toward personalized medicine and next-generation receptor modulators.
4.5.2 Growth (%) in adoption of bioinformatics and predictive analytics technologies in GPCR research workflows.
4.5.3 Increase (%) in demand for companion diagnostics and biomarker-driven therapeutic approaches globally.
5. G-Protein Coupled Receptors (GPCRs) Market Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Cell Lines
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Detection Kits
5.4 Cell Culture Reagents
5.5 Ligands
6. G-Protein Coupled Receptors (GPCRs) Market Analysis & Forecast, By Assay Type, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 cAMP Functional Assays
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Calcium Functional Assays
6.4 β-Arrestin Functional Assays
6.5 Radioligand Binding and GTPγS Functional Assays
6.6 Internalization Assays
6.7 Trafficking Assays
7. G-Protein Coupled Receptors (GPCRs) Market Analysis & Forecast, By End-User, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Pharmaceutical & Biotechnology Companies
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Academic & Research Institutes
7.4 Contract Research Organizations
8. G-Protein Coupled Receptors (GPCRs) Market Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Cancer Research
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 CNS Research
8.4 Metabolic Research
8.5 Cardiovascular Research
8.6 Inflammation Research
8.7 Respiratory Research
8.8 Others
9. G-Protein Coupled Receptors (GPCRs) Market Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Product, 2022–2035
9.2.3 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Assay Type, 2022–2035
9.2.4 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By End-User, 2022–2035
9.2.5 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Application, 2022–2035
9.2.6 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Product, 2022–2035
9.3.3 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Assay Type, 2022–2035
9.3.4 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By End-User, 2022–2035
9.3.5 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Application, 2022–2035
9.3.6 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Product, 2022–2035
9.4.3 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Assay Type, 2022–2035
9.4.4 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By End-User, 2022–2035
9.4.5 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Application, 2022–2035
9.4.6 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Product, 2022–2035
9.5.3 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Assay Type, 2022–2035
9.5.4 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By End-User, 2022–2035
9.5.5 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Application, 2022–2035
9.5.6 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Product, 2022–2035
9.6.3 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Assay Type, 2022–2035
9.6.4 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By End-User, 2022–2035
9.6.5 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Application, 2022–2035
9.6.6 G-Protein Coupled Receptors (GPCRs) Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022–2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Thermo Fisher Scientific Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Merck KGaA, Revvity Inc. (formerly PerkinElmer)
10.6.3 Abcam plc (Danaher)
10.6.4 Promega Corporation
10.6.5 BMG LABTECH GmbH
10.6.6 Eurofins Scientific SE
10.6.7 Isogenica Ltd.
10.6.8 BD Biosciences
10.6.9 QIAGEN N.V.
10.6.10 Enzo Life Sciences Inc.
10.6.11 Bio-Rad Laboratories Inc.
10.6.12 Tocris Bioscience (Bio-Techne)
10.6.13 HD Biosciences Co. Ltd.
10.6.14 GenScript Biotech Corporation
10.6.15 Novo Nordisk A/S
10.6.16 Takeda Pharmaceutical Company Ltd.
10.6.17 AstraZeneca plc
10.6.18 Cube Biotech GmbH
10.6.19 Sosei Heptares
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
North America dominated the G-Protein Coupled Receptors (GPCRs) Market in 2025 with approximately 37.10% of global revenues, led by the United States' world-class pharmaceutical and biotechnology R&D ecosystem, exceptional academic GPCR research institutions, the presence of all major GPCR research tool suppliers' primary commercial operations, and the extraordinary commercial momentum of GLP-1 receptor-targeted therapeutics driving unprecedented investment in next-generation GPCR drug discovery programs.
Cancer Research dominated the market in 2025 with approximately 31.2% of revenues, driven by the extraordinary breadth of GPCR involvement in oncological processes including tumor proliferation signaling, angiogenesis, metastatic invasion facilitation, and tumor microenvironment immune modulation that collectively make GPCRs among the most multifaceted and attractive target classes in the rapidly expanding oncology drug discovery sector.
Cell Lines dominated the market in 2025 with approximately 46.1% of revenues, reflecting their foundational role as the essential biological substrate for every category of GPCR functional assay across pharmaceutical drug screening, receptor characterization, biased signaling quantification, and mechanistic pharmacology research conducted by pharmaceutical companies, CROs, and academic institutions globally.
The G-Protein Coupled Receptors (GPCRs) Market was valued at USD 4.14 billion in 2025.
The G-Protein Coupled Receptors (GPCRs) Market is expected to grow at a CAGR of 4.94% from 2026 to 2035.
Get in Touch
